Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma

Toni Choueiri, MD of the Dana-Farber Cancer Center, Boston, MA discusses the Phase III METEOR randomized clinical trial of cabozantinib vs everolimus in advanced clear cell renal cell carcinoma (ccRCC... Author: VJOncology Added: 08/17/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts